✦ LIBER ✦

Late-Onset Cytomegalovirus (CMV) in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?

✍ Scribed by Schoeppler, K. E.; Lyu, D. M.; Grazia, T. J.; Crossno, J. T.; Vandervest, K. M.; Zamora, M. R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of prophylaxis with cytogam alone

✍ Robert M Kruger; Subramanian Paranjothi; Gregory A Storch; John P Lynch; Elbert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

167 The Importance of CMV Prophylaxis Du

✍ M. Delgado Roel; J.M. Borro Mate; M. Paradela de la Morena; M. De La Torre Bravo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Quantification of cytomegalovirus (CMV)

✍ Sangeeta M Bhorade; Chirag Sandesara; Edward R Garrity; Wickii T Vigneswaran; Lo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 180 KB

697 Extended Valganciclovir Prophylaxis

✍ L. Minces; M.H. Nguyen; E.J. Kwak; F. Silveira; J. Pilewski; M. Crespo; Y. Toyod 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Comparison of the efficacy and cost effe

✍ Janet Kelly; Dana Hurley; Ganesh Raghu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB